Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation
University Health Network · University of Toronto · +4 more institutions
Abstract
Therapeutic targeting of acute myeloid leukemia (AML) is hampered by intra- and inter-tumoral cell state heterogeneity. To develop a more precise understanding of AML cell states, we constructed a reference atlas of human hematopoiesis from 263,159 single-cell transcriptomes spanning 55 cellular states. Using this atlas, we mapped more than 1.2 million cells spanning 318 leukemia samples, revealing 12 recurrent patterns of aberrant differentiation in AML. Notably, this uncovered unexpected AML cell states resembling lymphoid and erythroid progenitors that were prognostic within the clinically heterogeneous context of normal karyotype AML, independent of genomic classifications. Systematic mapping of…
Citation impact
- FWCI
- 76.38
- Percentile
- 100%
- References
- 100
Authors
15- AGAndy G.X. ZengCorresponding
University Health Network, University of Toronto, Princess Margaret Cancer Centre
- IIIlaria Iacobucci
St. Jude Children's Research Hospital
- SSSayyam Shah
University Health Network, Princess Margaret Cancer Centre
- AMAmanda Mitchell
University Health Network, Princess Margaret Cancer Centre
- GWGordon Wong
University Health Network, University of Toronto, Princess Margaret Cancer Centre
Topics & keywords
- Atlas (anatomy)
- Haematopoiesis
- Biology
- Hierarchy
- Genetics
- Computational biology
- Evolutionary biology
- Stem cell
- Good health and well-being
Funding
- ALAlex's Lemonade Stand Foundation for Childhood Cancer
- SJSt. Jude Children's Research HospitalAwards: CA021765, P30 CA021765
- PMPrincess Margaret Cancer Foundation
- ALAmerican Lebanese Syrian Associated CharitiesAward: CA021765
- GOGovernment of Ontario
- CCCanadian Cancer SocietyAward: 703212
- IDInternational Development Research Centre
- CRCanada Research Chairs
- TFTerry Fox Foundation
- UOUniversity of Toronto
- CFCanada First Research Excellence Fund
- NINational Institutes of HealthAwards: CA197695, CA021765, P30 CA021765, R35 CA197695
- CICanadian Institutes of Health ResearchAward: RN380110-409786
- NCNational Cancer InstituteAwards: R35 CA197695, CA021765, P30 CA021765, CA197695